openPR Logo
Press release

๐—”๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ฒ ๐—•๐š๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž & ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ - ๐๐จ๐ฌ๐ญ๐

09-16-2024 03:24 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

๐—”๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ฒ ๐—•๐š๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ || 2024-2031

๐—”๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ฒ ๐—•๐š๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ || 2024-2031

The global angioplasty balloons market was valued at USD 2.2 billion in 2023 and is anticipated to grow significantly, reaching USD 2.9 billion by 2031. During the forecast period of 2024-2031, the market is projected to grow at a compound annual growth rate (CAGR) of 3.5%.

Angioplasty balloons are essential devices utilized in percutaneous transluminal angioplasty (PTA), a procedure primarily used to address cardiovascular conditions, particularly coronary artery disease. These balloons are instrumental in treating acute cardiac events such as heart attacks, where their timely deployment can help reopen blocked arteries, restore blood flow, and reduce heart muscle damage. The global growth of the angioplasty balloons market is propelled by the rising prevalence of cardiovascular diseases, an increasing preference for minimally invasive surgeries, and the growing geriatric population, which is more prone to heart-related issues.

๐†๐ž๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐๐ƒ๐… -https://www.datamintelligence.com/download-sample/angioplasty-balloons-market

๐Š๐ž๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ:

โ€ข On June 17, 2020, the U.S. Food and Drug Administration (FDA) approved the INFINITY Angioplasty Balloon platform, designed specifically for the treatment of peripheral artery disease (PAD) through percutaneous transluminal angioplasty (PTA). The innovative balloon platform was developed to enhance PAD therapy outcomes.

โ€ข In November 2020, Infinity Angioplasty Balloon Co. announced the commercial availability of the Infinity Angioplasty Balloon Catheter, following the successful completion of a First-in-Human clinical trial. This marked a significant milestone in expanding treatment options for PAD patients.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ:

The global rise in cardiovascular diseases (CVD) presents a significant public health challenge, driven by multiple factors such as unhealthy diets, sedentary lifestyles, tobacco use, obesity, high blood pressure, high cholesterol levels, diabetes, and aging populations. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, responsible for an estimated 18 million deaths annually. This trend reflects the urgent need for preventive measures and treatments for cardiovascular conditions.

CVDs encompass various disorders of the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and rheumatic heart disease. Notably, heart attacks and strokes account for over 80% of CVD-related deaths, with one-third of these fatalities occurring in individuals under 70. Behavioral risk factors, including unhealthy eating, lack of physical activity, smoking, and excessive alcohol consumption, play a critical role in heart disease and stroke incidence. Consequently, the increasing prevalence of CVDs is a key driver of market growth in the healthcare sector, particularly for products and interventions aimed at treating and preventing these conditions.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

โžก By Product Type: Drug Eluting Balloons, Normal Balloons, Cutting/Scoring Balloons.

โžก By Application: Coronary Angioplasty, Peripheral Angioplasty.

โžก By End-User: Hospitals, Ambulatory Surgical Centers, Others.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.datamintelligence.com/customize/angioplasty-balloons-market

๐Œ๐š๐ฃ๐จ๐ซ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

โ€ข Boston Scientific Corporation
โ€ข BIOTRONIK
โ€ข Medtronic Plc
โ€ข Cordis (Cardinal Health)
โ€ข Terumo Corporation
โ€ข Abbott Laboratories
โ€ข AngioDynamics
โ€ข BD
โ€ข INFINITY Angioplasty Balloon
โ€ข Koninklijke Philips N.V.

*๐๐จ๐ญ๐ž:

**๐“๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ฏ๐ž๐ซ๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ž๐ฌ ๐š๐ง ๐ข๐ง-๐๐ž๐ฉ๐ญ๐ก ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ž๐ฆ๐ž๐ซ๐ ๐ข๐ง๐  ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐ฌ๐ญ๐š๐ซ๐ญ๐ฎ๐ฉ๐ฌ, ๐ฐ๐ก๐ข๐œ๐ก ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ฏ๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ž ๐ž๐ฏ๐จ๐ฅ๐ฏ๐ข๐ง๐  ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฅ๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž ๐š๐ง๐ ๐ค๐ž๐ฒ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ ๐›๐ž๐ข๐ง๐  ๐š๐๐จ๐ฉ๐ญ๐ž๐**

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Coronary Stents Market: https://datamintelligence.com/research-report/coronary-stents-market

Bare Metal Stents Market: https://datamintelligence.com/research-report/bare-metal-stents-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ๐—”๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ฒ ๐—•๐š๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž & ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ - ๐๐จ๐ฌ๐ญ๐ here

News-ID: 3656764 • Views: โ€ฆ

More Releases from DataM Intelligence 4market Research LLP

Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Treatment Opportunities through 2031 | Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi.
Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Tre โ€ฆ
The Global RNAi Therapeutics Market is estimated to reach at a high CAGR 17.4% during the forecast period (2024-2031). The RNAi therapeutics market includes drugs that use RNA interference mechanisms to silence specific genes responsible for disease. These therapies offer precision treatment options for cancers, viral infections, and genetic disorders. Market growth is driven by increasing investment in biotechnology, rising prevalence of target diseases, and clinical trial advancements. Delivery systems suchโ€ฆ
United States Natural Fiber Composite Market Outlook 2024-2031: Sustainable Materials, Automotive Applications, and Industrial Growth | AERT, Beyer GmbH & Co. Kg, Procotex Corp SA
United States Natural Fiber Composite Market Outlook 2024-2031: Sustainable Mate โ€ฆ
Global Natural Fiber Composite Market reached US$ 327.0 Million in 2023 and is expected to reach US$ 494.3 Million by 2031, growing with a CAGR of 5.3% during the forecast period 2024-2031. The natural fiber composite market focuses on materials made by combining natural fibers such as jute, flax, hemp, or sisal with polymer matrices. These composites are used in automotive, construction, packaging, and consumer goods for lightweight, sustainable, and eco-friendlyโ€ฆ
United States Electrochemical Sensors Market Growth Outlook: Nanomaterials, Wireless Connectivity, and IoT-Enabled Solutions Shaping the Industry
United States Electrochemical Sensors Market Growth Outlook: Nanomaterials, Wire โ€ฆ
The Electrochemical Sensors Market is valued at a significant CAGR during the forecast period (2024-2031). The electrochemical sensors market covers devices that detect chemical species using electrochemical reactions to generate measurable signals. Applications include healthcare diagnostics, environmental monitoring, food safety, and industrial process control. Market growth is driven by demand for point-of-care testing, wearable devices, and real-time monitoring. Advances in miniaturization, nanomaterials, and wireless connectivity enhance sensor performance. Integration with IoTโ€ฆ
United States Bauxite Market Outlook 2024-2031: Rising Aluminum Demand and Industrial Applications Driving Growth | Rio Tinto, Alcoa Corporation, Guinea Alumina Corporation.
United States Bauxite Market Outlook 2024-2031: Rising Aluminum Demand and Indus โ€ฆ
Global Bauxite Market reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2031, growing with a CAGR of 3.7% during the forecast period 2024-2031. The bauxite market involves the mining and processing of bauxite ore, the primary raw material for aluminum production. It is also used in refractory materials, abrasives, and chemicals. Market growth is driven by increasing aluminum demand in automotive, aerospace, and packagingโ€ฆ

All 5 Releases


More Releases for Angioplasty

Angioplasty Balloons Market Research Report 2024
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ-ย  Angioplasty Balloons Market was valued at USD 2.16 Billion in 2023 and is projected to reach USD 2.77 Billion by 2030, growing at a CAGR of 3.17% from 2024 to 2030. Angioplasty Balloons Market Growth Driver The growth of the angioplasty balloons market is primarily driven by technological advancements in medical devices, increasing prevalence of cardiovascular diseases, and growing demand for minimally invasive procedures. Angioplasty balloons play a crucialโ€ฆ
Cutting Angioplasty Balloon Market - Revolutionizing Vascular Care: Precision, P โ€ฆ
Newark, New Castle, USA - new report, titled Cutting Angioplasty Balloon Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Cutting Angioplasty Balloon market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Cutting Angioplasty Balloon market. The report offers an overview ofโ€ฆ
Angioplasty Balloon Market is Fueled by Increasing of Demand for Angioplasty Bal โ€ฆ
The Angioplasty Balloon Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. View Report - https://www.theinsightpartners.com/reports/angioplasty-balloon-market/ Angioplasty balloon is used in various interventional procedures for the treatmentโ€ฆ
Angioplasty Balloons Market Report Up to 2031
Visiongain has published a new report on Angioplasty Balloons Market Report to 2031: Forecasts By Product Type (Normal, Drug-Eluting, and Cutting & Scoring Balloons), By Application (Coronary Artery Disease and Peripheral Artery Diseases) PLUS COVID-19 Recovery Scenarios. How has COVID-19 Impacted on Angioplasty Balloons Market COVID-19 pandemic adversely affected over 200 countries worldwide. Companies have been pressured to upsurge production capacity and raise the supply of products and other commodities. The pandemicโ€ฆ
Estimation: Angioplasty Balloons Market COVID-19 impact
The global angioplasty balloons market is estimated to surpass $3,043.8 million by 2027, exhibiting a CAGR of 3.3% from 2020 to 2027. OFFERINGS OF THE REPORT: The report offers comprehensive analysis of the global angioplasty balloons market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also sheds light onโ€ฆ
03-15-2021 | Health & Medicine
Fact.MR
Angioplasty Balloons Market: Semi-compliant balloons to be the most preferred an โ€ฆ
Balloon angioplasty is increasingly being used to carry out various specific tasks during surgeries, such as scoring, cutting, and drug eluting. Manufacturers of angioplasty balloons are focusing on improving patient outcomes by constantly upgrading their existing products. Balloon angioplasty is widely preferred for being minimally-invasive, and can be performed under local anaesthesia, wherein, the patient can be discharged within 24 hours after the surgery, in most cases. Moreover, drug-coated balloonโ€ฆ